RG
SOPH icon

Rathbones Group’s SOPHiA GENETICS SOPH Stock Holding History

Rathbones Group’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$647K Sell
112,133
-37,000
-25% -$188K ﹤0.01% 439
2026
Q1 		$738K Sell
149,133
-11,000
-7% -$53.5K ﹤0.01% 410
2025
Q4 		$748K Sell
160,133
-2,350
-1% -$10.6K ﹤0.01% 398
2025
Q3 		$773K Hold
162,483
– – ﹤0.01% 382
2025
Q2 		$504K Buy
+162,483
New +$484K ﹤0.01% 434

Other funds holding SOPH

BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
NS
NBC Securities Birmingham, Alabama $1.48B AUM 31.07% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Rathbones Group's SOPH Position: Q2 2026 in Review

Rathbones Group reduced its SOPHiA GENETICS (SOPH) stake by 25% in Q2 2026, selling an estimated $188K and leaving 112,133 shares worth $647K. The position accounts for ﹤0.01% of the portfolio, ranked #439.

Rathbones Group first reported a position in SOPH in Q2 2025 and has held it in 5 quarters since. The position peaked at $773K in Q3 2025. 9 funds tracked by Wall St. Rank hold SOPH as of Q2 2026.

  • Rathbones Group held 112,133 shares of SOPHiA GENETICS worth $647K as of Q2 2026.
  • Rathbones Group sold 37,000 SOPHiA GENETICS shares in Q2 2026, an estimated $188K.
  • SOPHiA GENETICS made up ﹤0.01% of Rathbones Group's portfolio in Q2 2026, its #439 holding.
  • Rathbones Group first reported a position in SOPHiA GENETICS in Q2 2025 and has held it in 5 quarters since.
  • Rathbones Group's SOPHiA GENETICS position peaked at $773K in Q3 2025.
  • 9 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2026.

Based on Rathbones Group's 13F filing for Q2 2026, filed 23 Jul 2026.